These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9487171)

  • 21. Is intensive drug therapy appropriate for older patients?
    Gollub SB
    Lancet; 1999 Mar; 353(9157):940-1. PubMed ID: 10459896
    [No Abstract]   [Full Text] [Related]  

  • 22. [Aspirin vs ticlid and their combination in patients with acute myocardial infarction].
    Vyshlov EV; Panfilova EV; Markov VA
    Klin Med (Mosk); 2000; 78(1):37-9. PubMed ID: 10697373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Challenging delays in thrombolysis.
    Quinn T
    Emerg Nurse; 2005 Feb; 12(9):9; author reply 9. PubMed ID: 15751460
    [No Abstract]   [Full Text] [Related]  

  • 24. Aspirin augmentation of the efficacy of thrombolysis.
    O'Donnell CJ; Jonas MA; Hennekens CH
    Coron Artery Dis; 1995 Dec; 6(12):936-9. PubMed ID: 8723015
    [No Abstract]   [Full Text] [Related]  

  • 25. NICE recommends ticagrelor with aspirin for three years post-MI.
    Wise J
    BMJ; 2016 Aug; 354():i4438. PubMed ID: 27520305
    [No Abstract]   [Full Text] [Related]  

  • 26. Beta-blockers and antithrombotics for secondary prevention after myocardial infarction.
    Ball SG
    Eur Heart J; 1998 Jan; 19(1):14-5. PubMed ID: 9503172
    [No Abstract]   [Full Text] [Related]  

  • 27. Management of hyperglycaemia in the patient with acute myocardial infarction.
    Nattrass M
    Diabet Med; 2003 Jun; 20 Suppl 3():11-3. PubMed ID: 12786673
    [No Abstract]   [Full Text] [Related]  

  • 28. Challenging the conclusions drawn in "Thrombolysis for acute myocardial infarction: drug review".
    Howlett M
    MedGenMed; 2002 Feb; 4(1):6; author reply 7. PubMed ID: 11965208
    [No Abstract]   [Full Text] [Related]  

  • 29. Acute myocardial infarction treatments in 58 Italian hospitals: a drug utilization survey.
    Venturini F; Romero M; Tognoni G
    Ann Pharmacother; 1995 Nov; 29(11):1100-5. PubMed ID: 8573952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Challenging delays in thrombolysis.
    Castle N; Owen R
    Emerg Nurse; 2004 Dec; 12(8):18-22. PubMed ID: 15635926
    [No Abstract]   [Full Text] [Related]  

  • 31. Time delays in provision of thrombolytic treatment in six district hospitals. Joint Audit Committee of the British Cardiac Society and a Cardiology Committee of Royal College of Physicians of London.
    Birkhead JS
    BMJ; 1992 Aug; 305(6851):445-8. PubMed ID: 1392956
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aspirin after thrombolysis for MI.
    Seaton TL
    J Fam Pract; 1997 Mar; 44(3):249-50. PubMed ID: 9071241
    [No Abstract]   [Full Text] [Related]  

  • 33. Pre-hospital opiate and aspirin administration in patients with suspected myocardial infarction.
    Wyllie HR; Dunn FG
    BMJ; 1994 Mar; 308(6931):760-1. PubMed ID: 7695672
    [No Abstract]   [Full Text] [Related]  

  • 34. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation.
    Sabatine MS; Cannon CP; Gibson CM; López-Sendón JL; Montalescot G; Theroux P; Claeys MJ; Cools F; Hill KA; Skene AM; McCabe CH; Braunwald E;
    N Engl J Med; 2005 Mar; 352(12):1179-89. PubMed ID: 15758000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiaggregating therapy in acute myocardial infarction.
    Cimminiello C; Uberti T; Fiorista F; Marzegalli M
    Eur Heart J; 1991 Dec; 12 Suppl G():30-2. PubMed ID: 1806377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Guideline implementation fails to improve thrombolytic administration.
    Kinsman L; Tori K; Endacott R; Sharp M
    Accid Emerg Nurs; 2007 Jan; 15(1):27-33. PubMed ID: 17218102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determinants of pre-hospital pharmacological intervention and its association with outcome in acute myocardial infarction.
    Strandmark R; Herlitz J; Axelsson C; Claesson A; Bremer A; Karlsson T; Jimenez-Herrera M; Ravn-Fischer A
    Scand J Trauma Resusc Emerg Med; 2015 Dec; 23():105. PubMed ID: 26626732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patency, perfusion, performance--the desirable triplets of combination thrombolytic therapy.
    Wilcox R
    Eur Heart J; 2000 Sep; 21(18):1495-7. PubMed ID: 10973761
    [No Abstract]   [Full Text] [Related]  

  • 39. Aspirin and suspected myocardial infarction.
    Shetty BK
    BMJ; 1994 Jun; 308(6945):1713-4. PubMed ID: 8025482
    [No Abstract]   [Full Text] [Related]  

  • 40. Heparin as an adjuvant to thrombolytic therapy in acute myocardial infarction.
    Metz BK; Topol EJ
    Biomed Pharmacother; 1996; 50(6-7):243-53. PubMed ID: 8952863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.